| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80b056d4ec182cd786f087e0ed09854d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 |
| filingDate |
2020-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ef70617b5d96c9d56bf03ce193b04e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f724d55b5d4d5e5323e560ddc5c05d2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_079182fe5222f7bce1028dc72877be55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_658c7ab31f7e9975a384b1e237de014b |
| publicationDate |
2022-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220011956-A |
| titleOfInvention |
Pharmaceutical composition for preventing or treating cell senescence associated diseases comprising lanatoside C |
| abstract |
The present invention relates to a pharmaceutical composition for the prevention or treatment of cell aging-related diseases containing lanatoside-C as an active ingredient, wherein the lanatoside-C contains cellular functions of senescence-induced fibroblasts and retinal pigment epithelial cells and As it was confirmed that it exhibited a senomorphix effect that restores shape and a senolytic effect that selectively kills senescence-induced vascular endothelial cells, the lanatoside-C acts differently depending on the cell type. As it has been confirmed that it effectively prevents or treats cardiovascular and ocular diseases caused by aging, lanatoside-C is provided as a senolytic and senomorphix drug, and as a therapeutic agent for cardiovascular and ocular diseases caused by cellular aging would like to provide |
| priorityDate |
2020-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |